Created at	Source	Raw Value	Validated value
Oct. 26, 2020, 7:26 a.m.	eu	(1) Assess the efficacy of favipiravir in addition to standard care in patients with COVID-19 in reducing the severity of disease compared to standard care alone	(1) Assess the efficacy of favipiravir in addition to standard care in patients with COVID-19 in reducing the severity of disease compared to standard care alone